Since their discovery in 2006, induced pluripotent stem cells (iPSCs) have opened up a
world of possibilities for regenerative medicine and novel cell-based therapeutics. Now, over …

The discovery of human embryonic stem cells (hESCs) raised promises for a universal
resource for cell based therapies in regenerative medicine. Recently, fast-paced progress …

Hematopoietic differentiation of human induced pluripotent stem cells (iPSCs) provide
opportunities not only for fundamental research and disease modelling/drug testing but also …

Over the past decade, enormous progress has been made in the field of induced pluripotent
stem cells (iPSCs). Patients' somatic cells such as skin fibroblasts or blood cells can be used …

The burst of reprogramming technology in recent years has revolutionized the field of stem
cell biology, offering new opportunities for personalized, regenerative therapies. The direct …

In vitro cultured blood cells for transfusion purposes provide a safe alternative to donor
blood, particularly for patients who require recurrent transfusions, and can be used as …

The ever-improving technology to generate induced pluripotent stem cells (iPSCs) has
increased their potential use as novel candidates for disease modeling, drug screening …

The generation of hematopoietic stem cells (HSCs) from induced pluripotent stem cells
(iPSCs) is an active and promising area of research; however, generating engraftable HSCs …

Generation of induced pluripotent stem cells (iPSCs) has revolutionized the field of
regenerative medicine by providing researchers with a unique tool to derive disease-specific …

A major breakthrough in the past 5 years is the development of the ability to reprogram
somatic cells to pluripotency. It has rejuvenated the field of stem cell research, providing …